Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:SURF

Surface Oncology (SURF) Stock Price, News & Analysis

Surface Oncology logo

About Surface Oncology Stock (NASDAQ:SURF)

Advanced Chart

Key Stats

Today's Range
$1.07
$1.07
50-Day Range
$0.88
$1.08
52-Week Range
$0.56
$1.43
Volume
N/A
Average Volume
430,375 shs
Market Capitalization
$65.08 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SURF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Surface Oncology and its competitors with MarketBeat's FREE daily newsletter.

SURF Stock News Headlines

Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.
Q3 2024 Heron Therapeutics Inc Earnings Call
See More Headlines

SURF Stock Analysis - Frequently Asked Questions

Surface Oncology, Inc. (NASDAQ:SURF) issued its quarterly earnings data on Thursday, November, 4th. The company reported ($0.44) earnings per share for the quarter, missing analysts' consensus estimates of ($0.40) by $0.04. The business earned $0.39 million during the quarter.

Surface Oncology (SURF) raised $84 million in an IPO on Thursday, April 19th 2018. The company issued 6,000,000 shares at $13.00-$15.00 per share. Goldman Sachs, Cowen and Evercore ISI served as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Surface Oncology investors own include Meta Platforms (META), NVIDIA (NVDA), CrowdStrike (CRWD), NIO (NIO), Zoom Communications (ZM), QUALCOMM (QCOM) and Workhorse Group (WKHS).

Company Calendar

Last Earnings
11/04/2021
Today
7/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:SURF
CIK
1718108
Fax
N/A
Employees
35
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$63.59 million
Pretax Margin
-211.95%

Debt

Sales & Book Value

Annual Sales
$30 million
Price / Cash Flow
N/A
Book Value
$0.81 per share
Price / Book
1.32

Miscellaneous

Free Float
53,525,000
Market Cap
$65.08 million
Optionable
Not Optionable
Beta
1.75
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:SURF) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners